कोशिश गोल्ड - मुक्त
Tata Capital board to discuss plan for rights issue
Business Standard
|February 22, 2025
Meeting set to take place on Tuesday
The board of Tata Capital, the financial services arm of the Tata Sons, is set to meet on Tuesday to discuss plans to raise capital through a rights issue, as per the company's filings. This comes as the company faces a deadline to list its shares by September this year, following a directive from the Reserve Bank of India (RBI) that requires all upper-layer Non-Banking Financial Companies to list by then.
यह कहानी Business Standard के February 22, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Business Standard से और कहानियाँ
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Business Standard
India faces 2nd highest economic burden due to diabetes: Study
India faces the second highest economic burden due to diabetes of $11.4 trillion — the United States bears the highest costs at $16.5 trillion, and China the third at $11 trillion, a new study has estimated.
2 mins
January 13, 2026
Business Standard
Nissan strengthens India leadership, appoints Thierry Sabbagh prez
Nissan has announced aseries of senior management changes in its Africa, Middle East, India, Europe and Oceania (AMIEO) region.
1 mins
January 13, 2026
Business Standard
THE MANAGEMENT REVOLUTION — BRIDGING THE GAP BETWEEN THEORY AND TOMORROW
The landscape of higher learning has evolved most dramatically within management studies over the last several decades.
2 mins
January 13, 2026
Listen
Translate
Change font size
